SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus April 28, 2026 mental-health ONLY AVAILABLE IN PAID PLANS. Originally reported by timesargus. Read more Source: https://www.timesargus.com/news/business/saphnelo-approved-in-the-us-for-subcutaneous-self-administration-as-a-new-autoinjector-for-the/article_818662b9-bb4f-58a1-bc54-632d1e158027.html
